Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 source : Www.immunic-therapeutics.com save search
Immunic, Inc. Announces FDA Clearance to Begin IMU-838 Phase 3 ENSURE Studies in Relapsing-Remitting Multiple Sclerosis and Phase 2 CALLIPER Study in Progressive Multiple Sclerosis
Published: 2021-07-01 (Crawled : 11:00) - immunic-therapeutics.com
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 3.02%
H: 3.17%
C: 2.38%
multiple sclerosis fda clearance fda phase 2 sclerosis phase 3 clearance imu-838
Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis
Published: 2021-02-18 (Crawled : 18:21) - immunic-therapeutics.com
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.94%
H: 2.54%
C: -19.04%
phase 2 positive trial topline sclerosis sclerosing cholangitis imu-838
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.